Related Experiment Video
Updated: May 25, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Impediments to clinical research in the United States
J M Kramer1, P B Smith, R M Califf
1Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. judith.kramer@duke.edu
Abstract:
Clinical trials are essential to the evaluation of promising scientific discoveries, but they are becoming unsustainably burdensome, threatening to deprive patients and health-care providers of new therapies and new evidence to guide the use of existing treatments. Regulations are often blamed for impeding clinical research, but there are other elements of the clinical trials enterprise that also have the potential to add burdens, through either imposed requirements or incentives that do not favor clinical research (Figure 1).
Insights
Clinical trials face significant burdens that hinder the development of new therapies. Addressing these challenges is crucial for advancing medical research and patient care.
Area of Science:
- Clinical research methodology
- Health services research
Background:
- Clinical trials are vital for evaluating new scientific discoveries and treatments.
- The increasing burden of clinical trials threatens patient access to novel therapies and evidence-based care.
Purpose of the Study:
- To identify and analyze the multifaceted burdens impacting clinical trials.
- To explore factors beyond regulations that contribute to the unsustainability of clinical research.
Main Methods:
- Review of existing literature on clinical trial operations.
- Analysis of regulatory and non-regulatory components of the clinical trials enterprise.
Main Results:
- While regulations are often cited, other operational and incentive-based elements significantly contribute to trial burdens.
- These non-regulatory factors can impose requirements or create disincentives for clinical research.
Conclusions:
- A comprehensive understanding of all contributing factors is necessary to alleviate clinical trial burdens.
- Addressing these multifaceted challenges is essential to ensure the continued progress of medical innovation and patient benefit.
Related Concept Videos
Ethics in Research
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Regulation
Preclinical Development: Overview
Longitudinal Research
